Shemar Moore Announces the Passing of his Mother Marilyn
Die-hard fans of actor Shemar Moore know that he had an extremely close relationship with his mother, as he often posted videos and photos...
The Boster Center for Multiple Sclerosis
Dr. Aaron Boster, neuroimmunologist, made a long-awaited announcement today via his YouTube channel. The Boster Center for Multiple Sclerosis is now open in northern...
New Six-year Ocrevus (Ocrelizumab) Data Showed That Earlier Initiation and Continuation of Treatment Reduced...
Post-hoc analysis from a Phase III open-label extension study showed a 42% reduction in the risk of PPMS patients needing a wheelchair after...
Two New Drugs Now Available to Treat SPMS
The FDA-approved medications offer additional treatment options for people living with active secondary progressive multiple sclerosis (SPMS).
Until the last few months, the vast majority...
FDA Approves Siponimod (Mayzent ) for Multiple Sclerosis
The US Food and Drug Administration (FDA) has approved siponimod (Mayzent®) tablets to treat adults with relapsing forms of multiple sclerosis (MS), to include...
NMSS announces University of California scientist as winner of Barancik Prize for Innovation in...
The National Multiple Sclerosis Society has announced Katerina Akassoglou, Ph.D., a leading researcher at the Gladstone Institute of Neurological Disease and the Department of...
Novartis Announces FDA and EMA Filing Acceptance of Siponimod for Secondary Progressive Multiple Sclerosis...
Novartis announced this week that both the US Food and Drug Administration (FDA) and European Medicines Agency (EMA) have accepted the company's New Drug...
Phase 2 Trial of Ibudilast Shows Slowing of Brain Shrinkage in Progressive MS
Patients living with primary progressive multiple sclerosis have eagerly been awaiting the results from phase 2 of the ibudilast study. It is the hope...
Mayo Clinic develops neuro test that distinguishes demyelinating diseases from MS
If you are like me and first presented with vision loss, transverse myelitis, neuromyelitis optica, or other inflammatory demyelinating disease that was not distinguishable...
Researchers discover new subtype of multiple sclerosis
Cleveland Clinic researchers have discovered a new subtype of multiple sclerosis (MS), providing a better understanding of the individualized nature of the disease.MS has...
